Item 5. Other Information

RULE 10B5-1 TRADING ARRANGEMENT

The following table includes the material terms of each trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) under the Securities Exchange Act of 1934, as amended ("Rule 10b5-1 Plan") by our executive officers and directors during the three months ended October 3, 2025.


Name and title			Date of adoption(1)						Date of termination						Scheduled expiration date(2)						Aggregate number of shares of common stock to be purchased or sold(3)
Elizabeth M. Porter, President Health & Civil			September 12, 2025						N/A						April 8, 2026						Up to 8,000 shares

(1) Transactions under each Rule 10b5-1 Plan commence no earlier than 90 days after adoption, or such later date as required by Rule 10b5-1.

(2) Each Rule 10b5-1 Plan may expire on such earlier date as all transactions are completed.

(3) Each Rule 10b5-1 Plan provides for shares to be sold on multiple predetermined dates.


Leidos Holdings, Inc.			33

Table of Contents

PART II—OTHER INFORMATION

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits